Barr Settles Suit Alleging Company Kept Generic Contraceptive From Entering Market

Main Category: Women's Health / Gynecology
Also Included In: Sexual Health / STDs;  Litigation / Medical Malpractice;  Pharma Industry / Biotech Industry
Article Date: 29 Feb 2008 - 7:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:not yet rated


Barr Pharmaceuticals has agreed to pay $5.9 million to settle a lawsuit alleging that Barr accepted $20 million from Warner Chilcott for agreeing to not sell a generic version of Warner's oral contraceptive Ovcon for five years, the Wall Street Journal reports. The lawsuit, filed by 34 states and Washington, D.C., in the U.S. District Court for the District of Columbia, alleged the agreement violated state and federal antitrust laws and artificially inflated the price of Ovcon. The settlement prohibits Barr from entering into noncompetition agreements with companies that sell brand-name drugs for the next 10 years (Gryta, Wall Street Journal, 2/26).

According to the suit, Barr received FDA approval for a generic form of Ovcon in 2004 and was planning to sell it at 30% less than Warner's price (AP/Yahoo! Finance, 2/27). In June 2007, Warner agreed to pay $5.5 million to settle its portion of the lawsuit. In addition, Warner agreed not to make agreements that could keep potential generic competitors from entering the market (Daily Women's Health Policy Report, 6/15/07).

Barr spokesperson Carol Cox said Barr has not admitted any wrongdoing and continues to believe the agreement with Warner was "legal, legitimate and pro-competitive." She added, "In addition, the settlement does not significantly alter Barr's ability to do business" (Wall Street Journal, 2/26). Iowa Attorney General Tom Miller said, "When generic drugs come on the market, it almost always results in competition and lower prices" (AP/Yahoo! Finance, 2/27).

Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.

© 2007 The Advisory Board Company. All rights reserved.

Article adapted by Medical News Today from original press release.
Visit our women's health / gynecology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
National Partnership for Women & Families. "Barr Settles Suit Alleging Company Kept Generic Contraceptive From Entering Market." Medical News Today. MediLexicon, Intl., 29 Feb. 2008. Web.
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/98976.php>

APA
National Partnership for Women & Families. (2008, February 29). "Barr Settles Suit Alleging Company Kept Generic Contraceptive From Entering Market." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/98976.php.

Please note: If no author information is provided, the source is cited instead.


Women's Health / Gynecology

Most Popular Articles



Follow Our Women's Health News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Women's Health / Gynecology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »